LEVOHEARTSHOCK

Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock. (LevoHeartShock)

Pr Bruno LEVY

Coordonnateur du projet LevoHeartShock

Promoteur : CHRU Nancy
Site internet
Coordonnateur : CIC-P
Site internet
LEVOHEARTSHOCK : Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock. (LevoHeartShock)

Financé par le ministère de la santé PHRC 2018
CLINICALTRIALS.GOV